United States · FDA National Drug Code directory
carisoprodol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-852_21e58fc9-d824-4d1d-e063-6294a90a2acc
- Product NDC
- 76420-852
- Form
- TABLET
- Composition / generic term
- carisoprodol
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161108
- Source listing expiry
- 20261231
Source-listed ingredients
- CARISOPRODOL — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (76420-852-01) · 76420-852-01
- 30 TABLET in 1 BOTTLE (76420-852-30) · 76420-852-30
- 60 TABLET in 1 BOTTLE (76420-852-60) · 76420-852-60
- 90 TABLET in 1 BOTTLE (76420-852-90) · 76420-852-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →